- Home
- BRNS
as 04-24-2025 3:32pm EST
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
| Founded: | 2016 | Country: | United Kingdom |
| Employees: | N/A | City: | DIDCOT |
| Market Cap: | 28.2M | IPO Year: | 2021 |
| Target Price: | $3.00 | AVG Volume (30 days): | 25.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.64 - $2.60 | Next Earning Date: | 05-12-2025 |
| Revenue: | $14,969,000 | Revenue Growth: | 1766.46% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Barinthus Biotherapeutics plc News
BRNS Breaking Stock News: Dive into BRNS Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
ACCESS Newswire
a month ago
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
ACCESS Newswire
2 months ago
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
Simply Wall St.
3 months ago
US Exchange Insights: 3 Penny Stocks With Over $40M Market Cap
GlobeNewswire
3 months ago
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
Simply Wall St.
4 months ago
Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar
GlobeNewswire
5 months ago
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
GlobeNewswire
5 months ago
Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
Compare BRNS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRNS Barinthus Biotherapeutics plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.